Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal …
Lung cancer, with its high mortality and increasing morbidity, has become one of the most
lethal malignancies worldwide. Here, we developed cyclic RGD peptide-directed and …
lethal malignancies worldwide. Here, we developed cyclic RGD peptide-directed and …
SC‐Dynamic R‐CNN: A Self‐Calibrated Dynamic R‐CNN Model for Lung Cancer Lesion Detection
X Wang, L Wang, P Zheng - Computational and Mathematical …, 2022 - Wiley Online Library
Lung cancer has complex biological characteristics and a high degree of malignancy. It has
always been the number one “killer” in cancer, threatening human life and health. The …
always been the number one “killer” in cancer, threatening human life and health. The …
[HTML][HTML] Combination of 18f-fluorodeoxyglucose pet/ct radiomics and clinical features for predicting epidermal growth factor receptor mutations in lung …
S Li, Y Li, M Zhao, P Wang, J Xin - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Objective To identify epidermal growth factor receptor (EGFR) mutations in lung
adenocarcinoma based on 18 F-fluorodeoxyglucose (FDG) PET/CT radiomics and clinical …
adenocarcinoma based on 18 F-fluorodeoxyglucose (FDG) PET/CT radiomics and clinical …
Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers
Objectives Procalcitonin (PCT) is widely used for the diagnosis of bacterial infections. The
aim of this study was to evaluate PCT as a tumor and as a prognostic marker in patients with …
aim of this study was to evaluate PCT as a tumor and as a prognostic marker in patients with …
[HTML][HTML] Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer
Tumour suppressor genes play a cardinal role in the development of a large array of human
cancers, including lung cancer, which is one of the most frequently diagnosed cancers …
cancers, including lung cancer, which is one of the most frequently diagnosed cancers …
[HTML][HTML] High expression of PSRC1 predicts poor prognosis in lung adenocarcinoma
R Han, Y Guan, M Tang, M Li, B Zhang, G Fei… - Journal of …, 2023 - ncbi.nlm.nih.gov
Background: The incidence of lung cancer is increasing annually, but the mechanism of its
occurrence and development requires further study. This study aimed to investigate the …
occurrence and development requires further study. This study aimed to investigate the …
[HTML][HTML] Lung cancer epidemiology in Korea
A Shin, CM Oh, BW Kim, H Woo… - … : Official Journal of …, 2017 - synapse.koreamed.org
Purpose The current study was undertaken to examine the trends in the lung cancer
incidence, mortality, and survival after a diagnosis in Korea. Materials and Methods Lung …
incidence, mortality, and survival after a diagnosis in Korea. Materials and Methods Lung …
Incidence of lung adenocarcinoma by age, sex, and smoking status in Taiwan
LH Chien, HF Jiang, FY Tsai, HY Chang… - JAMA Network …, 2023 - jamanetwork.com
Importance Knowing whether the effects of smoking and other risk factors with lung
adenocarcinoma (ADC) incidence varies by sex would provide information on lung cancer …
adenocarcinoma (ADC) incidence varies by sex would provide information on lung cancer …
Epigenetic regulation of EMT in non-small cell lung cancer
K O'Leary, A Shia, P Schmid - Current cancer drug targets, 2018 - ingentaconnect.com
Lung cancer remains the most diagnosed cancer in the world, with a high mortality rate and
fewer therapeutic options. The most common lung cancer is non-small cell, consisting of …
fewer therapeutic options. The most common lung cancer is non-small cell, consisting of …
Identification of a four-gene panel predicting overall survival for lung adenocarcinoma
C Li, Q Long, D Zhang, J Li, X Zhang - BMC cancer, 2020 - Springer
Background Lung cancer is the most frequently diagnosed carcinoma and the leading cause
of cancer-related mortality. Although molecular targeted therapy and immunotherapy have …
of cancer-related mortality. Although molecular targeted therapy and immunotherapy have …